ISO 20776-1:2019

Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices — Part 1: Broth micro-dilution reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases

Publication date:   Jun 5, 2019

General information

90.92   Standard to be revised   Nov 28, 2025

ISO

ISO/TC 212 Clinical laboratory testing and in vitro diagnostic test systems

International Standard

11.100.20   Biological evaluation of medical devices

Buying

  Published

PDF - €163.35

  English   French  



Buy

Scope

This document describes one reference method, broth micro-dilution, for determination of MICs. The MIC can be a guide for the clinician, and reflects the activity of the drug under the described test conditions, by taking into account other factors, such as drug pharmacology, pharmacokinetics, or bacterial resistance mechanisms. This allows categorisation of bacteria as "susceptible" (S), "intermediate" (I), or "resistant" (R). In addition, MIC distributions can be used to define wild type or non-wild type bacterial populations. Although clinical interpretation of the MIC value is beyond the scope of this document, modifications of the basic method are required for certain antimicrobial agent - bacteria combinations to facilitate clinical interpretation. These modifications are included in a separate annex of this document. It is necessary to compare other susceptibility testing methods (e.g. disc diffusion or diagnostic test devices) with this reference method for validation, in order to ensure comparable and reliable results.

Life cycle

PREVIOUSLY

WITHDRAWN
ISO 20776-1:2006

NOW

PUBLISHED
ISO 20776-1:2019
90.92 Standard to be revised
Nov 28, 2025

REVISED BY

IN_DEVELOPMENT
ISO/CD 20776-1